Literature DB >> 5494063

Cerebral lipids in a case of systemic Gm2-gangliosidosis of a late infantile type.

C Klibansky, A Saifer, N I Feldman, L Schneck, B W Volk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5494063     DOI： 10.1111/j.1471-4159.1970.tb02220.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  6 in total

Review 1.  Progress in investigations of sphingolipidoses.

Authors:  M Adachi; L Schneck; B W Volk
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

2.  Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients.

Authors:  E M Brett; R B Ellis; L Haas; J U Ikonne; B D Lake; A D Patrick; R Stephens
Journal:  Arch Dis Child       Date:  1973-10       Impact factor: 3.791

3.  GM2-gangliosidosis, AB variant: clinico-pathological study of a case.

Authors:  C M de Baecque; K Suzuki; I Rapin; A B Johnson; D L Whethers
Journal:  Acta Neuropathol       Date:  1975-12-19       Impact factor: 17.088

4.  Clinical and biochemical study of a child with the non-neuronopathic-Type B form of Niemann-Pick disease.

Authors:  D Reich; A Kedar; C Klibansky
Journal:  Eur J Pediatr       Date:  1979-05-18       Impact factor: 3.183

5.  The AB-variant of GM2-gangliosidosis. Clinical, biochemical, and pathological studies of two patients.

Authors:  J E Goldman; T Yamanaka; I Rapin; M Adachi; K Suzuki; K Suzuki
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

6.  Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.

Authors:  W G Johnson; C S Cohen; A F Miranda; S P Waran; A M Chutorian
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.